A novel NR3C2 polymorphism and the increased thyroid-stimulating hormone concentration are associated with venlafaxine treatment outcome in Chinese Han MDD patients

Authors:

Abstract
No abstract available
Funding Information
  • National Key Research and Development (2016YFC0906400, 2016YFC1307000, 2016YFC0905000, 2017YFC0909200)
  • National Natural Science Foundation of China (81671326, 81421061, 81361120389, 31701086)
  • Shanghai Key Laboratory of Psychotic (13dz2260500)
  • Shanghai Leading Academic Discipline (B205)